# A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)

> **NCT01688791** · PHASE1 · TERMINATED · sponsor: **Endocyte** · enrollment: 37 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Vintafolide
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01688791
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688791, "A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01688791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*